Melanoma/Skin Cancer News

Patients with Merkel cell carcinoma have an increased risk for developing subsequent primary solid tumors and hematologic malignancies, according to data published in JAMA Dermatology.

Survivors of cutaneous melanoma, especially those diagnosed at a young age, were at an increased risk for secondary primary cancers compared with the general population, according to a study.

A higher proportion of patients are dying from nonmelanoma skin cancer globally than melanoma, according to a press release from the European Academy of Dermatology and Venerology.

Greater travel time appeared associated with reduced participation in genotype-matched clinical trials among patients with cancer who underwent comprehensive genomic profiling, according to results of a study conducted in Japan.

The FDA approved nivolumab as adjuvant treatment of adult and pediatric patients 12 years and older with completely resected stage IIB or IIC melanoma, according to the agent’s manufacturer.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Delaying post-operative radiation therapy for the treatment of Merkel cell carcinoma beyond 8 weeks significantly increased patients’ risk for locoregional recurrence, according to a study.

Information AI-powered chatbots provided related to search queries on the most common cancer types generally produced accurate information with poor actionability, study results published in JAMA Oncology showed.

ASCO released a research statement outlining new recommendations regarding the appropriate assessment of ovarian toxicity in cancer clinical trials.

The FDA announced several regulatory actions.